Cargando…
Challenges and Opportunities for the Traceability of (Biological) Medicinal Products
This article provides an overview of the current situation regarding the traceability of medicinal products, with a focus on drug safety and biologics. Limited traceability of biologics, in particular with regard to the batch number, is associated with incomplete recording of exposure information in...
Autores principales: | Klein, Kevin, Stolk, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153964/ https://www.ncbi.nlm.nih.gov/pubmed/29721822 http://dx.doi.org/10.1007/s40264-018-0678-7 |
Ejemplares similares
-
Living Health Technology Assessment: Issues, Challenges and Opportunities
por: Thokala, Praveen, et al.
Publicado: (2023) -
Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges
por: Lamsal, Ramesh, et al.
Publicado: (2017) -
The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK
por: Klein, Kevin, et al.
Publicado: (2019) -
Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered
por: Valeur, Kristine Svinning, et al.
Publicado: (2018) -
Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports
por: Klein, Kevin, et al.
Publicado: (2015)